GMTX Gemini Therapeutics Inc

About GMTX

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel treatments for hematologic disorders. Its programs include Bitopertin, DISC-0974, and DISC-3405. The company was founded in October 2017 and is headquartered in Watertown, MA.
50

Neutral Sentiment

How do you feel about GMTX?

Advertisement|Remove ads.